Stay updated on Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page.

Latest updates to the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page
- Check3 days agoChange DetectedThe history now shows a new revision tag upgrading from v3.6.6 to v3.7.0, representing a new version entry for the study record history.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new Revision: v3.6.6 is added to the history and the previous Revision: v3.6.5 is removed. This reflects a minor platform/UI update to the record history display rather than any change to the study data.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedA new revision entry v3.6.5 is added to the study's revision history, and the previous revision v3.6.4 is removed. This reflects an update to the record's version history without altering the trial data.SummaryDifference0.1%

- Check52 days agoChange DetectedAdded revision v3.6.4 to the history and removed v3.6.3, reflecting a small update to the page’s version history.SummaryDifference0.1%

- Check81 days agoChange DetectedA newer revision entry (v3.6.3) was added to the record history and an older revision (v3.6.0) was removed, updating the history to reflect the latest version.SummaryDifference0.1%

- Check95 days agoChange DetectedThe study record shows recruitment has closed to new participants and the record has been revised to version v3.6.0, replacing the prior v3.5.5 label.SummaryDifference0.4%

Stay in the know with updates to Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page.